C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2004
12/30/2004	US20040267017 3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors
12/30/2004	US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
12/30/2004	US20040267010 For therapy of central nervous system disorders
12/30/2004	US20040266849 and atherosclerosis; LXR agonists which increase HDL levels; increases ABCA1 gene expression; reverse cholesterol transport; 1,2-benzisoxazole 6-yl compounds
12/30/2004	US20040266848 Preparation of N2-alkylated 1,2,3-triazoles
12/30/2004	US20040266840 Inhibits replication and/or proliferation of Hepatitis C virus (HCV)
12/30/2004	US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors
12/30/2004	US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
12/30/2004	US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis
12/30/2004	US20040266821 Obesity, diabetes, sexual dysfunction
12/30/2004	US20040266781 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/30/2004	US20040266769 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion
12/30/2004	US20040266763 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
12/30/2004	US20040266759 Possess antithrombotic and anticoagulant properties; example compound: 1-(5-Chlorobenzo[b]furan-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl]piperazine
12/30/2004	US20040266750 Beta-lactamyl vasopressin v1aantagonists
12/29/2004	WO2004113362A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions
12/29/2004	WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	WO2004113330A1 Immunosuppressant compounds and compositions
12/29/2004	WO2004113329A1 Oxazole derivatives as antibacterial agents
12/29/2004	WO2004113304A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
12/29/2004	WO2004113303A1 INDAZOLE/PYRZOLO[4,3-c]PYRIDIN DERIVATIVES AS JNK INHIBITORS, COMPOSITIONS AND METHODS RELATED THERETO AS WELL AS INTERMEDIATE THEREOF
12/29/2004	WO2004112719A2 Chemical compounds
12/29/2004	WO2004112709A2 Inhibitors of cathepsin s
12/29/2004	WO2004091502A3 1,2,4-oxadiazole benzoic acid compounds
12/29/2004	WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors
12/29/2004	WO2004075815A3 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
12/29/2004	WO2003099793A8 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/29/2004	EP1491533A2 Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors
12/29/2004	EP1491194A1 Vdac regulator
12/29/2004	EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage
12/29/2004	EP1490363A1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
12/29/2004	EP1490358A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
12/29/2004	EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
12/29/2004	EP1490350A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
12/29/2004	EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators
12/29/2004	EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
12/29/2004	EP1490334A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1490060A1 Antidiabetic agents
12/29/2004	EP1490059A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
12/29/2004	EP1490056A1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
12/29/2004	EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004	EP1233769A4 Novel compounds
12/29/2004	EP1230224B1 Substituted 5-benzyl-2,4-diaminopyrimidines
12/29/2004	EP1226136B1 Tyrosine kinase inhibitors
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	EP0941092B1 Use of nk-1 receptor antagonists for treating major depressive disorders
12/29/2004	EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase
12/29/2004	EP0929545B1 Tricyclic inhibitors of farnesyl protein transferase
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558898A Antiviral agent
12/29/2004	CN1558897A Antidiabetic agents
12/29/2004	CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1182123C Substituted bicyclic derivatives useful as anticancer agents
12/29/2004	CN1182114C Piperazine derivatives used as CCR5 antagonist
12/29/2004	CA2533480A1 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions
12/29/2004	CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	CA2524700A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/29/2004	CA2524027A1 Immunosuppressant compounds and compositions
12/28/2004	US6835845 Methine compound, material for organic luminescence element, and organic luminescence element using the same
12/28/2004	US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis
12/28/2004	US6835831 Efficient synthesis of ceramide-like compounds by reacting an aldehyde and an amidomethylisonitrile to form a 4-amido-2-oxazoline; suppress biosynthesis of glycosphingolipids; antitumor agents; Tays-Sach, Gaucher's
12/28/2004	US6835741 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835714 Heterocyclic compounds, intermediates thereof and elastase inhibitors
12/28/2004	US6835474 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
12/28/2004	US6835329 Photostability; hindered amine light stabilizers
12/23/2004	WO2004111039A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	WO2004111036A1 4- (heterocyclyl- fused phenyl)- 3- (phenyl or pyrid -2- yl) pyrazoles as inhibitors of the alk-5- receptor
12/23/2004	WO2004111032A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111030A1 Method for preparing fused oxazinones
12/23/2004	WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
12/23/2004	WO2004111013A1 Hepatitis c virus inhibitors
12/23/2004	WO2004111000A2 Piperidyl derivatives and their use as tachykinin antagonists
12/23/2004	WO2004110994A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/23/2004	WO2004110993A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110439A1 Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain
12/23/2004	WO2004110435A1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
12/23/2004	WO2004110433A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis
12/23/2004	WO2004110350A2 Compouds and uses thereof in modulating amyloid beta
12/23/2004	WO2004110344A2 New azetidine compounds
12/23/2004	WO2004091518A3 Cxcr4 chemokine receptor binding compounds
12/23/2004	WO2004078128A3 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/23/2004	WO2004076411A3 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
12/23/2004	WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
12/23/2004	WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments
12/23/2004	WO2004071447A3 Substituted azole derivatives as therapeutic agents
12/23/2004	WO2004055010A3 Cyclopropyl compounds as ccr5 antagonists
12/23/2004	WO2004032875A3 Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents
12/23/2004	WO2003093250A3 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/23/2004	US20040260098 Synthesis of epothilones, intermediates thereto and analogues thereof
12/23/2004	US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/23/2004	US20040259931 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259914 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula
12/23/2004	US20040259910 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors

1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 647